ConductScience.org, home

Paper2434476

Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

Cornwell MM and 2 others. J Biol Chem, 1987. Cited by 521 papers, by iCite.

Cite this record

ConductScience Library. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. Papers, record 2434476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2434476

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
PubMed
Journal
J Biol Chem
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
521
iCite
Relative citation ratio, by iCite
17.4
iCite
Revised in PubMed
2022-04-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cornwell MMM M
2Pastan II
3Gottesman MMM M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Calcium Channel BlockersMajor topic
CarcinomaMajor topic
GlycoproteinsMajor topic
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
ATP Binding Cassette Transporter, Subfamily B, Member 1
Cell Line
Diltiazem
Drug Resistance
Humans
Nitrendipine
Quinidine
Verapamil
Vinblastine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA07661NCI NIH HHSUnited StatesF32CA007661PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by106

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 521 citations.

PMIDTitleJournalYearIn PapersSource
38989058Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/38989058PubMed
38706362Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells.Anticancer Agents Med Chem2024https://conductscience.org/library/papers/38706362PubMed
38593161Pyrrole-based inhibitors of RND-type efflux pumps reverse antibiotic resistance and display anti-virulence potential.PLoS Pathog2024https://conductscience.org/library/papers/38593161PubMed
361427245-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells.Int J Mol Sci2022https://conductscience.org/library/papers/36142724PubMed
36046755The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells.Explor Target Antitumor Ther2021https://conductscience.org/library/papers/36046755PubMed
35989346The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial.Sci Rep2022https://conductscience.org/library/papers/35989346PubMed
35406579Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells.Cancers (Basel)2022https://conductscience.org/library/papers/35406579PubMed
35240035Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin.J Nat Prod2022https://conductscience.org/library/papers/35240035PubMed
34440646The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.Cells2021https://conductscience.org/library/papers/34440646PubMed
32857790Investigation of physiological and molecular mechanisms conferring diurnal variation in auxinic herbicide efficacy.PLoS One2020https://conductscience.org/library/papers/32857790PubMed
32403277Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.Molecules2020https://conductscience.org/library/papers/32403277PubMed
316809722-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels.Front Pharmacol2019https://conductscience.org/library/papers/31680972PubMed
31530935ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942.Oncogene2020https://conductscience.org/library/papers/31530935PubMed
31367189Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals.Cancer Cell Int2019https://conductscience.org/library/papers/31367189PubMed
30669343Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs-A Promising Approach to Fight Cancer Drug Resistance.Molecules2019https://conductscience.org/library/papers/30669343PubMed
29963035Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens.Front Microbiol2018https://conductscience.org/library/papers/29963035PubMed
29236701Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.PLoS One2017https://conductscience.org/library/papers/29236701PubMed
28243063Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study.Drug Des Devel Ther2017https://conductscience.org/library/papers/28243063PubMed
28210973Renal Drug Transporters and Drug Interactions.Clin Pharmacokinet2017https://conductscience.org/library/papers/28210973PubMed
28036031Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells.Pharmaceutics2016https://conductscience.org/library/papers/28036031PubMed

See all 106 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2434476

GET https://conductscience.org/api/papers/v1/2434476/cited_by?page=2